Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 6;15(1):2036.
doi: 10.1038/s41467-024-46211-0.

Deep learning model for personalized prediction of positive MRSA culture using time-series electronic health records

Affiliations

Deep learning model for personalized prediction of positive MRSA culture using time-series electronic health records

Masayuki Nigo et al. Nat Commun. .

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) poses significant morbidity and mortality in hospitals. Rapid, accurate risk stratification of MRSA is crucial for optimizing antibiotic therapy. Our study introduced a deep learning model, PyTorch_EHR, which leverages electronic health record (EHR) time-series data, including wide-variety patient specific data, to predict MRSA culture positivity within two weeks. 8,164 MRSA and 22,393 non-MRSA patient events from Memorial Hermann Hospital System, Houston, Texas are used for model development. PyTorch_EHR outperforms logistic regression (LR) and light gradient boost machine (LGBM) models in accuracy (AUROCPyTorch_EHR = 0.911, AUROCLR = 0.857, AUROCLGBM = 0.892). External validation with 393,713 patient events from the Medical Information Mart for Intensive Care (MIMIC)-IV dataset in Boston confirms its superior accuracy (AUROCPyTorch_EHR = 0.859, AUROCLR = 0.816, AUROCLGBM = 0.838). Our model effectively stratifies patients into high-, medium-, and low-risk categories, potentially optimizing antimicrobial therapy and reducing unnecessary MRSA-specific antimicrobials. This highlights the advantage of deep learning models in predicting MRSA positive cultures, surpassing traditional machine learning models and supporting clinicians' judgments.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Cumulative Incidence Curve of Positive MRSA Over Two Weeks in the MHHS and MIMIC-IV Datasets.
a and b show cumulative incidence of MRSA cultures in Memorial Hermann Hospital System (MHHS) and Medical Information Mart for Intensive Care (MIMIC)-IV datasets, respectively. Both figures were generated based on the risk predicted by our model in test datasets. Given the significant imbalance in the MIMIC-IV dataset, even high-risk patients achieved 20% positivity compared to the MHHS dataset. In contrast, the low-risk patient group had fewer false negatives. The shaded area in the graph represents the 95% confidence intervals. MHHS Memorial Hermann Hospital System, MIMIC Medical Information Mart for Intensive Care, MRSA Methicillin Resistant Staphylococcus aureus.
Fig. 2
Fig. 2. Schematic Structure of Deep Learning-Based Prediction Model for MRSA-Positive Cultures.
a summarizes the overall structure of the model used to predict MRSA-positive cultures over a two-week period from the index culture. Our model integrates multiple structural data tables from Electronic Health Records (EHRs) as time-sequenced data prior to the index time. A deep learning-based model (PyTorch_EHR) is employed to predict MRSA-positive cultures over two weeks from the index time. b describes scenarios where patients experience multiple events over time. EHR: Electronic Health Records, MRSA: Methicillin-Resistant Staphylococcus aureus.

References

    1. Liu C, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 2011;52:e18–e55. doi: 10.1093/cid/ciq146. - DOI - PubMed
    1. Fridkin SK, Sanza LT, Jernigan JA, Lynfield R. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 2005;352:1436–1444. doi: 10.1056/NEJMoa043252. - DOI - PubMed
    1. Moran GJ, Gorwitz RJ, McDougal LK. Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department. N. Engl J. Med. 2006;355:666–674. doi: 10.1056/NEJMoa055356. - DOI - PubMed
    1. Rybak M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am. J. Health Syst. Pharm. 2009;66:82–98. doi: 10.2146/ajhp080434. - DOI - PubMed
    1. Carey GB, et al. Estimated mortality with early empirical antibiotic coverage of methicillin-resistant Staphylococcus aureus in hospitalized patients with bacterial infections: a systematic review and meta-analysis. J. Antimicrob. Chemother. 2023;78:1150–1159. doi: 10.1093/jac/dkad078. - DOI - PubMed